name: Wilson Disease
category: Genetic
parents:
- Metabolic Disease
- Liver Disease
disease_term:
  preferred_term: Wilson disease
  term:
    id: MONDO:0010200
    label: Wilson disease
pathophysiology:
- name: Copper Accumulation
  description: >
    ATP7B mutations impair copper excretion into bile and incorporation into
    ceruloplasmin. Copper accumulates in liver, brain, and other organs.
    Free copper causes oxidative damage and cellular toxicity.
  evidence:
  - reference: PMID:37741465
    supports: SUPPORT
    snippet: "Inactivating mutations of the copper-transporting P-type ATPase, ATP7B, result in Wilson's disease, an autosomal recessive disorder"
    explanation: Establishes that ATP7B mutations are the causative defect in Wilson's disease.
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein."
    explanation: Confirms that impaired biliary copper excretion leads to hepatic copper accumulation.
  biological_processes:
  - preferred_term: Copper Transport
    term:
      id: GO:0006825
      label: copper ion transport
- name: Hepatocyte Injury
  description: >
    Copper accumulation in hepatocytes causes oxidative stress, mitochondrial
    dysfunction, and cell death. Progressive liver damage leads to fibrosis
    and cirrhosis.
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Excess Cu2+ primarily leads to the generation of reactive oxygen species (ROS), as evidenced by early experimental studies exemplified with the detection of hydroxyl radical formation"
    explanation: Demonstrates that excess copper generates ROS leading to oxidative stress and cellular injury.
  cell_types:
  - preferred_term: Hepatocyte
    term:
      id: CL:0000182
      label: hepatocyte
  biological_processes:
  - preferred_term: Oxidative Stress
    term:
      id: GO:0006979
      label: response to oxidative stress
- name: Neurodegeneration
  description: >
    Copper deposition in basal ganglia causes neuronal damage. Astrocyte
    swelling and neuroinflammation contribute to movement disorders and
    psychiatric symptoms.
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Released from the liver cells due to limited storage capacity, the toxic copper enters the circulation and arrives at other organs, causing local accumulation and cell injury. This explains why copper injures not only the liver, but also the brain"
    explanation: Explains the pathophysiology of copper-induced brain injury in Wilson's disease.
  biological_processes:
  - preferred_term: Neurodegeneration
    term:
      id: GO:0070997
      label: neuron death
phenotypes:
- name: Hepatomegaly
  category: Hepatic
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Copper accumulation in the liver is due to impaired biliary excretion of copper caused by the inheritable malfunctioning or missing ATP7B protein."
    explanation: Hepatic copper accumulation leads to hepatomegaly as an early manifestation of liver involvement.
  phenotype_term:
    preferred_term: Hepatomegaly
    term:
      id: HP:0002240
      label: Hepatomegaly
- name: Cirrhosis
  category: Hepatic
  frequency: FREQUENT
  notes: Can be presenting feature or develop over time
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Liver transplantation is an option viewed as ultima ratio in end-stage liver disease with untreatable complications or acute liver failure."
    explanation: End-stage liver disease including cirrhosis is a major complication requiring transplantation.
  phenotype_term:
    preferred_term: Cirrhosis
    term:
      id: HP:0001394
      label: Cirrhosis
- name: Kayser-Fleischer Rings
  category: Ocular
  frequency: VERY_FREQUENT
  diagnostic: true
  notes: Copper deposits in Descemet membrane, pathognomonic
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia, renal tubular dysfunction, Kayser-Fleischer corneal rings"
    explanation: Confirms Kayser-Fleischer rings as a key clinical feature of Wilson's disease due to copper deposition in the eyes.
  phenotype_term:
    preferred_term: Kayser-Fleischer Ring
    term:
      id: HP:0200032
      label: Kayser-Fleischer ring
- name: Tremor
  category: Neurological
  frequency: FREQUENT
  notes: Often wing-beating tremor
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "copper injures not only the liver, but also the brain, kidneys, eyes, heart, muscles, and bones, explaining the multifaceted clinical features of Wilson disease. Among these are depression, psychosis, dysarthria, ataxia"
    explanation: Neurological manifestations including movement disorders result from brain copper deposition.
  phenotype_term:
    preferred_term: Tremor
    term:
      id: HP:0001337
      label: Tremor
- name: Dysarthria
  category: Neurological
  frequency: FREQUENT
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Among these are depression, psychosis, dysarthria, ataxia, writing problems, dysphagia"
    explanation: Dysarthria is explicitly listed as a neurological manifestation of Wilson disease.
  phenotype_term:
    preferred_term: Dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
- name: Dystonia
  category: Neurological
  frequency: FREQUENT
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Neurological manifestations of Wilson disease include tremor, dystonia, parkinsonism, chorea, ataxia, and dysarthria."
    explanation: Dystonia is explicitly listed among the neurological manifestations of Wilson disease.
  phenotype_term:
    preferred_term: Dystonia
    term:
      id: HP:0001332
      label: Dystonia
- name: Psychiatric Symptoms
  category: Psychiatric
  frequency: FREQUENT
  notes: Depression, personality changes, psychosis
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Among these are depression, psychosis, dysarthria, ataxia, writing problems"
    explanation: Depression and psychosis are explicitly listed as neuropsychiatric manifestations of Wilson disease.
  phenotype_term:
    preferred_term: Psychiatric Abnormality
    term:
      id: HP:0000708
      label: Atypical behavior
biochemical:
- name: Ceruloplasmin
  presence: Decreased
  context: Low in over 90 percent of patients (less than 20 mg/dL)
- name: Serum Copper
  presence: Decreased
  context: Total serum copper often low (bound to ceruloplasmin)
- name: Free Copper
  presence: Elevated
  context: Non-ceruloplasmin-bound copper elevated
- name: 24-Hour Urinary Copper
  presence: Elevated
  context: Elevated urinary copper is diagnostic
- name: Hepatic Copper
  presence: Elevated
  context: Liver biopsy with elevated copper is diagnostic
genetic:
- name: ATP7B
  association: Causative
  notes: Autosomal recessive, over 500 mutations described
  evidence:
  - reference: PMID:37741465
    supports: SUPPORT
    snippet: "Inactivating mutations of the copper-transporting P-type ATPase, ATP7B, result in Wilson's disease, an autosomal recessive disorder"
    explanation: Establishes ATP7B mutations as the causative genetic defect in Wilson's disease.
environmental:
- name: Dietary Copper
  notes: High copper foods may accelerate accumulation
treatments:
- name: D-Penicillamine
  description: Copper chelator, first-line therapy, promotes urinary copper excretion.
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Patients with Wilson disease are well-treated first-line with copper chelators like D-penicillamine that facilitate the removal of circulating copper bound to albumin and increase in urinary copper excretion. Early chelation therapy improves prognosis."
    explanation: Establishes D-penicillamine as first-line chelation therapy with evidence for improved prognosis.
  treatment_term:
    preferred_term: copper chelator agent therapy
    term:
      id: MAXO:0001224
      label: copper chelator agent therapy
- name: Trientine
  description: Alternative copper chelator, better tolerated than penicillamine.
  evidence:
  - reference: PMID:37741465
    supports: SUPPORT
    snippet: "Current treatment protocols are limited to either sequestration of copper via chelation or reduction of copper absorption in the gut"
    explanation: Confirms chelation therapy as a primary treatment approach for Wilson's disease.
  treatment_term:
    preferred_term: copper chelator agent therapy
    term:
      id: MAXO:0001224
      label: copper chelator agent therapy
- name: Zinc Acetate
  description: Blocks intestinal copper absorption, maintenance therapy.
  evidence:
  - reference: PMID:37741465
    supports: SUPPORT
    snippet: "reduction of copper absorption in the gut (zinc therapy)"
    explanation: Confirms zinc therapy works by reducing intestinal copper absorption.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Low Copper Diet
  description: Avoid liver, shellfish, chocolate, nuts, mushrooms.
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Patients with Wilson disease are advised to adhere to a low-copper diet and to avoid foods with a high copper content such as liver, shellfish, nuts, chocolate, and mushrooms as part of their long-term management."
    explanation: Provides a direct recommendation for low-copper dietary restriction in Wilson disease, specifying avoidance of high-copper foods as part of treatment.
  treatment_term:
    preferred_term: dietary intervention
    term:
      id: MAXO:0000088
      label: dietary intervention
- name: Liver Transplantation
  description: Curative for hepatic Wilson disease, reverses copper metabolism defect.
  evidence:
  - reference: PMID:38731973
    supports: SUPPORT
    snippet: "Liver transplantation is an option viewed as ultima ratio in end-stage liver disease with untreatable complications or acute liver failure. Liver transplantation finally may thus be a life-saving approach and curative treatment of the disease by replacing the hepatic gene mutation."
    explanation: Confirms liver transplantation as curative treatment that replaces the defective gene.
  treatment_term:
    preferred_term: liver transplantation
    term:
      id: MAXO:0001175
      label: liver transplantation
datasets:
